Eric L. Dong

FDA investigator · also recorded as Of Mis Eric Dong

Appears on 4 documents from 2016 to 2021, mostly at sites in Maryland. Most often cites written procedures; deviations (21 CFR 211.100).

4
Documents on file
8.3
Observations per 483
2016
First seen
2021
Most recent

What they cite most

From 32 observations

Activity by year

2016: 2, 2019: 1, 2021: 1

Where

Maryland 2 · India 1 · Texas 1

Often inspects with

Deyaa Shaheen· Dipesh K. Shah· Qin Xu

Is Eric L. Dong coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Smith & Nephew Wound ManagementJul 20, 2021 · Fort Worth, Texas
483 Aparna Pharmaceuticals Private LimitedMar 15, 2019 · Srikakulam, India
483 Eisai, IncJul 22, 2016 · Baltimore, Maryland
483 Pharmaceutics International, Inc.Apr 4, 2016 · Cockeysville, Maryland

About this profile

What does Eric L. Dong inspect?

Eric L. Dong appears on 4 documents on file covering 4 sites, mostly in Maryland.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Eric L. Dong is dated Jul 20, 2021.